Paclitaxel liposome with anti–HER-2 drugs as first-line therapy for recurrent/metastatic HER-2–positive breast cancer: a real-world study.
| Publicado en: | Holistic Integrative Oncology Vol. 5; no. 1; pp. 1 - 12 |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
Springer Nature
8/11/2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |